HELIOS: Phase 3 trial of ibrutinib combined with bendamustine and rituximab in previously treated CLL/SLL | Dr Paula Cramer at EHA 2015

At the 20th Congress of the European Hematology Association (EHA), Paula Cramer, MD, of the University Hospital Cologne, Cologne, Germany, discusses the first results from the phase 3 HELIOS trial, wh... Author: EMJ Added: 06/29/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts